You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Hims
since
auto-detected in 32 stories
46 days ago
These are the stocks posting the largest moves in midday trading.
54 days ago
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves ⊕
Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.
89 days ago
Stocks making the biggest moves premarket: Bumble, Hims & Hers Health, Blue Owl, Netskope & more ○
These are the stocks posting the largest moves in premarket trading.
2 months ago
Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more ○
found
These are some of the stocks seeing the largest midday moves.
3 months ago
Stocks making the biggest moves midday: Chevron, Hims and Hers, Xenon Pharma, Vertiv and more ○
These are some of the stocks posting the largest midday moves.
Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs ⊖
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
Stocks making the biggest moves premarket: AMD, Home Depot, Hims & Hers Health, Diamondback Energy and more ⊕
These are the stocks posting the largest moves in early trading.
Stocks making the biggest moves premarket: Walmart, Hims & Hers, Carvana, Figma & more ○
These are the stocks posting the largest moves in the premarket.
Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion ⊕
found
The deal would give Hims & Hers a foothold in Australia and Japan while deepening its presence in the United Kingdom, Germany, and Canada.
Wegovy maker sues rival over 'knock-off' weight-loss drugs ⊖
Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".